Benzinga | Nov 3, 2021 05:20PM EDT

Vanda Pharmaceuticals Q3 EPS $0.14 Misses $0.16 Estimate, Sales $70.09M Miss $75.00M Estimate

Vanda Pharmaceuticals (NASDAQ:VNDA) reported quarterly earnings of $0.14 per share which missed the analyst consensus estimate of $0.16 by 12.5 percent. This is a 27.27 percent increase over earnings of $0.11 per share from the same period last year. The company reported quarterly sales of $70.09 million which missed the analyst consensus estimate of $75.00 million by 6.54 percent. This is a 16.23 percent increase over sales of $60.31 million the same period last year.